These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19133984)

  • 1. Persistent (current) in the face of adversity ... a new class of cardiac anti-ischaemic compounds on the horizon?
    Saint DA
    Br J Pharmacol; 2009 Jan; 156(2):211-3. PubMed ID: 19133984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F 15845 inhibits persistent sodium current in the heart and prevents angina in animal models.
    Vacher B; Pignier C; Létienne R; Verscheure Y; Le Grand B
    Br J Pharmacol; 2009 Jan; 156(2):214-25. PubMed ID: 19133985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of persistent sodium current by F 15845 prevents ischaemia-induced arrhythmias.
    Pignier C; Rougier JS; Vié B; Culié C; Verscheure Y; Vacher B; Abriel H; Le Grand B
    Br J Pharmacol; 2010 Sep; 161(1):79-91. PubMed ID: 20718741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranolazine vs phenytoin: greater effect of ranolazine on the transient Na(+) current than on the persistent Na(+) current in central neurons.
    Terragni B; Scalmani P; Colombo E; Franceschetti S; Mantegazza M
    Neuropharmacology; 2016 Nov; 110(Pt A):223-236. PubMed ID: 27450092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole protects against cardiac ischaemia and reperfusion damage via block of the persistent sodium current.
    Weiss S; Benoist D; White E; Teng W; Saint DA
    Br J Pharmacol; 2010 Jul; 160(5):1072-82. PubMed ID: 20590601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiac persistent sodium current: an appealing therapeutic target?
    Saint DA
    Br J Pharmacol; 2008 Mar; 153(6):1133-42. PubMed ID: 18071303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-(R)-[3-(2-methoxyphenylthio-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine bromhydrate (F 15845) prevents ischemia-induced heart remodeling by reduction of the intracellular Na+ overload.
    Vié B; Sablayrolles S; Létienne R; Vacher B; Darmellah A; Bernard M; Feuvray D; Le Grand B
    J Pharmacol Exp Ther; 2009 Sep; 330(3):696-703. PubMed ID: 19515969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of resurgent and persistent sodium currents in mesencephalic trigeminal neurons.
    Enomoto A; Seki S; Tanaka S; Ishihama K; Yamanishi T; Kogo M; Hamada S
    J Neurosci Res; 2018 Feb; 96(2):305-312. PubMed ID: 28752895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?
    Makielski JC; Valdivia CR
    Br J Pharmacol; 2006 May; 148(1):4-6. PubMed ID: 16520741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na+ currents in cardioprotection: better to be late.
    Le Grand B; Pignier C; Létienne R; Colpaert F; Cuisiat F; Rolland F; Mas A; Borras M; Vacher B
    J Med Chem; 2009 Jul; 52(14):4149-60. PubMed ID: 19514733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the persistent sodium current a specific target of anti-absence drugs?
    Niespodziany I; Klitgaard H; Margineanu DG
    Neuroreport; 2004 Apr; 15(6):1049-52. PubMed ID: 15076732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of protein kinase C increases neuronal excitability by regulating persistent Na+ current in mouse neocortical slices.
    Astman N; Gutnick MJ; Fleidervish IA
    J Neurophysiol; 1998 Sep; 80(3):1547-51. PubMed ID: 9744958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardium.
    Shryock JC; Belardinelli L
    Br J Pharmacol; 2008 Mar; 153(6):1128-32. PubMed ID: 18071302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent and resurgent Na
    Meredith FL; Rennie KJ
    J Neurophysiol; 2020 Aug; 124(2):510-524. PubMed ID: 32667253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a patch clamp screening protocol that simultaneously measures compound activity in multiple states of the voltage-gated sodium channel Nav1.2.
    Liu Y; Beck EJ; Flores CM
    Assay Drug Dev Technol; 2011 Dec; 9(6):628-34. PubMed ID: 21675872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of eslicarbazepine on persistent Na⁺ current and the role of the Na⁺ channel β subunits.
    Doeser A; Soares-da-Silva P; Beck H; Uebachs M
    Epilepsy Res; 2014 Feb; 108(2):202-11. PubMed ID: 24368131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons.
    Nakamura M; Cho JH; Shin H; Jang IS
    Eur J Pharmacol; 2019 Jul; 855():175-182. PubMed ID: 31063770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modulation of two motor behaviors by persistent sodium currents in
    Svensson E; Jeffreys H; Li WC
    J Neurophysiol; 2017 Jul; 118(1):121-130. PubMed ID: 28331009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent sodium currents in neurons: potential mechanisms and pharmacological blockers.
    Müller P; Draguhn A; Egorov AV
    Pflugers Arch; 2024 Oct; 476(10):1445-1473. PubMed ID: 38967655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium channel blocking and antiarrhythmic actions of the novel arylpiperazine rsd992.
    Hayes ES; Pugsley MK; Goldin AL; Walker MJ
    Pharmacol Res; 2002 Jul; 46(1):19-27. PubMed ID: 12208117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.